Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AP0302 (S-Ibuprofen) for DOMS
NCT03852459Phase 2Completed
- Sponsor
- Aponia Laboratories
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexibuprofen in delayed onset muscle soreness (DOMS), sponsored by Aponia Laboratories. Started Jan 2018; status: completed.
02
Drugs
dexibuprofen
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT03852459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03852459.